 
            
                           Motilal Oswal's research report on SBI Life Insurance
SBILIFE reported an inline 4QFY23. APE grew 10% YoY (inline), while VNB grew 23% YoY, as margins expanded 380bp QoQ to 31.6%, driven by higher growth in Non-PAR. PAT grew 16% YoY to INR7.8b (10% beat). Among segments, Annuity saw a healthy growth of 78% YoY, while Non-Par savings grew 65% YoY in 4QFY23. Growth in the Protection business was modest at 12% YoY, while the ULIP business saw a decline. We slightly lower our VNB margin estimates and expect VNB margins to remain at ~30% in FY25. We expect SBILIFE to deliver a 20% CAGR in APE over FY23-25, thus enabling a 20% VNB CAGR. RoEV is expected to hover around ~22-23%. We reiterate our BUY rating on the stock.
Outlook
We estimate a 20% CAGR in APE over FY32-25 and estimate VNB margin to remain at ~30% in FY25, thus enabling a 20% VNB CAGR. RoEV is expected to stay around ~22%. We reiterate our BUY rating with a TP of INR1,500 (2.4x Sep’24E EV).
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.